Mizuho reissued their buy rating on shares of Healthpeak Properties (NYSE:DOC – Free Report) in a research report report published on Monday, MarketBeat Ratings reports. They currently have a $22.00 price target on the real estate investment trust’s stock.
A number of other research analysts also recently weighed in on DOC. StockNews.com upgraded shares of Healthpeak Properties from a sell rating to a hold rating in a research report on Friday, April 5th. Compass Point decreased their price objective on shares of Healthpeak Properties from $19.00 to $18.00 and set a buy rating for the company in a research report on Tuesday, January 2nd. Wells Fargo & Company assumed coverage on shares of Healthpeak Properties in a research report on Monday, March 25th. They issued an equal weight rating and a $19.00 price objective for the company. KeyCorp reissued a sector weight rating on shares of Healthpeak Properties in a research note on Friday, January 5th. Finally, Bank of America raised shares of Healthpeak Properties from an underperform rating to a buy rating and boosted their target price for the stock from $18.00 to $25.00 in a research note on Monday, April 1st. Six analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of Hold and an average price target of $18.10.
Read Our Latest Analysis on Healthpeak Properties
Healthpeak Properties Trading Up 1.4 %
Institutional Trading of Healthpeak Properties
Several large investors have recently bought and sold shares of DOC. Norges Bank purchased a new stake in Healthpeak Properties during the 4th quarter valued at about $34,883,000. Leeward Investments LLC MA purchased a new stake in Healthpeak Properties during the 4th quarter valued at about $13,038,000. abrdn plc grew its stake in Healthpeak Properties by 1,749.1% during the 4th quarter. abrdn plc now owns 919,351 shares of the real estate investment trust’s stock valued at $12,237,000 after acquiring an additional 869,631 shares in the last quarter. Angelo Gordon & CO. L.P. purchased a new stake in Healthpeak Properties during the 4th quarter valued at about $3,713,000. Finally, Charles Schwab Investment Management Inc. grew its stake in Healthpeak Properties by 6.5% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 3,943,465 shares of the real estate investment trust’s stock valued at $52,488,000 after acquiring an additional 239,972 shares in the last quarter. Hedge funds and other institutional investors own 93.57% of the company’s stock.
About Healthpeak Properties
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Featured Stories
- Five stocks we like better than Healthpeak Properties
- 3 Ways To Invest In Coffee, Other Than Drinking It
- It’s Time to Buy Into the Super Micro Computer Stock Implosion
- Why Are Stock Sectors Important to Successful Investing?
- Merger or Not, Albertson’s Companies is a Good Buy
- Dividend Payout Ratio Calculator
- 3 Cheap Stocks That Shouldn’t Be So
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.